Xencor Inc (XNCR)
22.26
-0.17
(-0.76%)
USD |
NASDAQ |
Mar 28, 13:20
Xencor Shareholders Equity (Quarterly): 668.80M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 668.80M |
September 30, 2023 | 669.01M |
June 30, 2023 | 678.88M |
March 31, 2023 | 683.58M |
December 31, 2022 | 727.50M |
September 30, 2022 | 722.70M |
June 30, 2022 | 742.34M |
March 31, 2022 | 763.02M |
December 31, 2021 | 733.50M |
September 30, 2021 | 618.86M |
June 30, 2021 | 646.94M |
March 31, 2021 | 583.61M |
December 31, 2020 | 572.44M |
September 30, 2020 | 568.48M |
June 30, 2020 | 570.64M |
March 31, 2020 | 593.00M |
December 31, 2019 | 593.20M |
September 30, 2019 | 610.24M |
June 30, 2019 | 608.09M |
March 31, 2019 | 609.56M |
December 31, 2018 | 521.68M |
September 30, 2018 | 532.27M |
Date | Value |
---|---|
June 30, 2018 | 519.18M |
March 31, 2018 | 537.66M |
December 31, 2017 | 316.46M |
September 30, 2017 | 290.54M |
June 30, 2017 | 301.36M |
March 31, 2017 | 303.75M |
December 31, 2016 | 313.95M |
September 30, 2016 | 202.42M |
June 30, 2016 | 208.60M |
March 31, 2016 | 158.81M |
December 31, 2015 | 162.43M |
September 30, 2015 | 153.32M |
June 30, 2015 | 162.07M |
March 31, 2015 | 169.30M |
December 31, 2014 | 59.29M |
September 30, 2014 | 59.71M |
June 30, 2014 | 65.52M |
March 31, 2014 | 70.06M |
December 31, 2013 | 73.53M |
September 30, 2013 | 4.572M |
June 30, 2013 | 3.994M |
December 31, 2012 | -19.50M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
568.48M
Minimum
Sep 2020
763.02M
Maximum
Mar 2022
648.22M
Average
632.90M
Median
Shareholders Equity (Quarterly) Benchmarks
Ionis Pharmaceuticals Inc | 386.69M |
Karyopharm Therapeutics Inc | -136.21M |
NovaBay Pharmaceuticals Inc | 7.037M |
Palatin Technologies Inc | -11.38M |
iBio Inc | 9.197M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 952.69M |
Total Liabilities (Quarterly) | 283.56M |
Debt to Equity Ratio | 0.0314 |
Current Ratio | 7.356 |
Net Debt Paydown Yield | -0.32% |